BIOAVAILABILITY OF CONVENTIONAL AND SLOW-RELEASE OXPRENOLOL IN FASTED AND NON-FASTED INDIVIDUALS

被引:15
作者
DAWES, CP
KENDALL, MJ
WELLING, PG
机构
关键词
D O I
10.1111/j.1365-2125.1979.tb00936.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The influence of food and plasma levels of oxprenolol was examined in healthy female volunteers using both conventional and slow‐release formulations. 2 There were no significant trends in plasma drug profiles due to food with either formulation. Elimination half‐lives were longer after food with conventional tablets, presumably due to continued absorption. The opposite effect was seen with slow‐release tablets. 3 Slow‐release oxprenolol is, under the conditions of this study, a reliable and convenient dosage form, providing similar plasma‐ drug profiles in fasted and nonfasted individuals. 1979 The British Pharmacological Society
引用
收藏
页码:299 / 302
页数:4
相关论文
共 13 条
[1]  
CLAPPER WILLIAM E., 1960, ANTIBIOT MED AND CLIN THER, V7, P91
[2]   SIMPLIFIED METHOD FOR DETERMINATION OF OXPRENOLOL AND OTHER BETA-RECEPTOR BLOCKING-AGENTS IN BIOLOGICAL-FLUIDS BY GAS-LIQUID-CHROMATOGRAPHY [J].
DEGEN, PH ;
RIESS, W .
JOURNAL OF CHROMATOGRAPHY, 1976, 121 (01) :72-75
[3]  
GRIFFITH R. S., 1960, ANTIBIOT MED AND CLIN THER, V7, P320
[4]  
JOSSELYN LE, 1952, ANTIBIOT CHEMOTHER, V3, P63
[5]   PLASMA METOPROLOL CONCENTRATIONS IN YOUNG, OLD AND HYPERTENSIVE SUBJECTS [J].
KENDALL, MJ ;
BROWN, D ;
YATES, RA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (04) :497-499
[6]  
KENDALL MJ, 1976, EUR J DRUG METAB PHA, V3, P155
[7]  
MASON WD, 1976, CLIN PHARMACOL THER, V20, P401
[8]  
MELANDER A, 1977, CLIN PHARMACOL THER, V22, P108
[9]  
SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112
[10]  
SMITH JW, 1953, JAMA-J AM MED ASSOC, V151, P805